Connect with us

News

Mars travelers can use ‘Star Trek’ Tricorder-like features using smartphone biotech: study

Published

on

Plans to take humans to the Moon and Mars come with numerous challenges, and the health of space travelers is no exception. One of the ways any ill-effects can be prevented or mitigated is by detecting relevant changes in the body and the body’s surroundings, something that biosensor technology is specifically designed to address on Earth. However, the small size and weight requirements for tech used in the limited habitats of astronauts has impeded its development to date.

A recent study of existing smartphone-based biosensors by scientists from Queen’s University Belfast (QUB) in the UK identified several candidates under current use or development that could be also used in a space or Martian environment. When combined, the technology could provide functionality reminiscent of the “Tricorder” devices used for medical assessments in the Star Trek television and movie franchises, providing on-site information about the health of human space travelers and biological risks present in their habitats.

Biosensors focus on studying biomarkers, i.e., the body’s response to environmental conditions. For example, changes in blood composition, elevations of certain molecules in urine, heart rate increases or decreases, and so forth, are all considered biomarkers. Health and fitness apps tracking general health biomarkers have become common in the marketplace with brands like FitBit leading the charge for overall wellness sensing by tracking sleep patterns, heart rate, and activity levels using wearable biosensors. Astronauts and other future space travelers could likely use this kind of tech for basic health monitoring, but there are other challenges that need to be addressed in a compact way.

The projected human health needs during spaceflight have been detailed by NASA on its Human Research Program website, more specifically so in its web-based Human Research Roadmap (HRR) where the agency has its scientific data published for public review. Several hazards of human spaceflight are identified, such as environmental and mental health concerns, and the QUB scientists used that information to organize their study. Their research produced a 20-page document reviewing the specific inner workings of the relevant devices found in their searches, complete with tables summarizing each device’s methods and suitability for use in space missions. Here are some of the highlights.

A chart showing the classification of scientific articles about relevant smartphone-based biosensors used in the Queen’s University Belfast study. | Credit: Biosensors/Queen’s University Belfast

Risks in the Spacecraft Environment

During spaceflight, the environment is a closed system that has a two-fold effect: One, the immune system has been shown to decrease its functionality in long-duration missions, specifically by lowering white blood cell counts, and two, the weightless and non-competitive environment make it easier for microbes to transfer between humans and their growth rates increase. In one space shuttle era study, the number of microbial cells in the vehicle able to reproduce increased by 300% within 12 days of being in orbit. Also, certain herpes viruses, such as those responsible for chickenpox and mononucleosis, have been reactivated under microgravity, although the astronauts typically didn’t show symptoms despite the presence of active viral shedding (the virus had surfaced and was able to spread).

Frequent monitoring of the spacecraft environment and the crew’s biomarkers is the best way to mitigate these challenges, and NASA is addressing these issues to an extent with traditional instruments and equipment to collect data, although often times the data cannot be processed until the experiments are returned to Earth. An attempt has also been made to rapidly quantify microorganisms aboard the International Space Station (ISS) via a handheld device called the Lab-on-a-Chip Application Development-Portable Test System (LOCAD-PTS). However, this device cannot distinguish between microorganism species yet, meaning it can’t tell the difference between pathogens and harmless species. The QUB study found several existing smartphone-based technologies generally developed for use in remote medical care facilities that could achieve better identification results.

NASA astronaut Karen Nyberg uses a fundoscope to image her eye while in orbit to study Visual Impairment Intracranial Pressure (VIIP) Syndrome. Smaller 3D printed retinal imaging adaptors for smartphones are being developed to perform the testing done by large devices similar to the instrument used here. | Credit: NASA

One of the devices described was a spectrometer (used to identify substances based on the light frequency emitted) which used the smartphone’s flashlight and camera to generate data that was at least as accurate as traditional instruments. Another was able to identify concentrations of an artificial growth hormone injected into cows called recominant bovine somatrotropin (rBST) in test samples, and other systems were able to accurately detect cyphilis and HIV as well as the zika, chikungunya, and dengue viruses. All of the devices used smartphone attachments, some of them with 3D-printed parts. Of course, the types of pathogens detected are not likely to be common in a closed space habitat, but the technology driving them could be modified to meet specific detection needs.

The Stress of Spaceflight

A group of people crammed together in a small space for long periods of time will be impacted by the situation despite any amount of careful selection or training due to the isolation and confinement. Declines in mood, cognition, morale, or interpersonal interaction can impact team functioning or transition into a sleep disorder. On Earth, these stress responses may seem common, or perhaps an expected part of being human, but missions in deep space and on Mars will be demanding and need fully alert, well-communicating teams to succeed. NASA already uses devices to monitor these risks while also addressing the stress factor by managing habitat lighting, crew movement and sleep amounts, and recommending astronauts keep journals to vent as needed. However, an all-encompassing tool may be needed for longer-duration space travels.

Advertisement
-

As recognized by the QUB study, several “mindfulness” and self-help apps already exist in the market and could be utilized to address the stress factor in future astronauts when combined with general health monitors. For example, the popular FitBit app and similar products collect data on sleep patterns, activity levels, and heart rates which could potentially be linked to other mental health apps that could recommend self-help programs using algorithms. The more recent “BeWell” app monitors physical activity, sleep patterns, and social interactions to analyze stress levels and recommend self-help treatments. Other apps use voice patterns and general phone communication data to assess stress levels such as “StressSense” and “MoodSense”.

A Tricorder-like setup is imagined by scientists at Queens University Belfast, utilizing the functionalities of existing smartphone-based biosensors. | Credit: Biosensors/Queens University Belfast

Advances in smartphone technology such as high resolution cameras, microphones, fast processing speed, wireless connectivity, and the ability to attach external devices provide tools that can be used for an expanding number of “portable lab” type functionalities. Unfortunately, though, despite the possibilities that these biosensors could mean for human spaceflight needs, there are notable limitations that would need to be overcome in some of the devices. In particular, any device utilizing antibodies or enzymes in its testing would risk the stability of its instruments thanks to radiation from galactic cosmic rays and solar particle events. Biosensor electronics might also be damaged by these things as well. Development of new types of shielding may be necessary to ensure their functionality outside of Earth and Earth orbit or, alternatively, synthetic biology could also be a source of testing elements genetically engineered to withstand the space and Martian environments.

The interest in smartphone-based solutions for space travelers has been garnering more attention over the years as tech-centric societies have moved in the “app” direction overall. NASA itself has hosted a “Space Apps Challenge” for the last 8 years, drawing thousands of participants to submit programs that interpret and visualize data for greater understanding of designated space and science topics. Some of the challenges could be directly relevant to the biosensor field. For example, in the 2018 event, contestants are asked to develop a sensor to be used by humans on Mars to observe and measure variables in their environments; in 2017, contestants created visualizations of potential radiation exposure during polar or near-polar flight.

While the QUB study implied that the combination of existing biosensor technology could be equivalent to a Tricorder, the direct development of such a device has been the subject of its own specific challenge. In 2012, the Qualcomm Tricorder XPRIZE competition was launched, asking competitors to develop a user-friendly device that could accurately diagnose 13 health conditions and capture 5 real-time health vital signs. The winner of the prize awarded in 2017 was Pennsylvania-based family team called Final Frontier Medical Devices, now Basil Leaf Technologies, for their DxtER device. According to their website, the sensors inside DxtER can be used independently, one of which is in a Phase 1 Clinical Trial. The second place winner of the competition used a smartphone app to connect its health testing modules and generate a diagnosis from the data acquired from the user.

The march continues to develop the technology humans will need to safely explore regions beyond Earth orbit. Space is hard, but it was hard before we went there the first time, and it was hard before we put humans on the moon. There may be plenty of challenges to overcome, but as the Queen’s University Belfast study demonstrates, we may already be solving them. It’s just a matter of realizing it and expanding on it.

Accidental computer geek, fascinated by most history and the multiplanetary future on its way. Quite keen on the democratization of space. | It's pronounced day-sha, but I answer to almost any variation thereof.

Advertisement
Comments

Investor's Corner

Tesla uber bull Ron Baron says ‘the time to buy the stock is now’

Published

on

Credit: Tesla

In a new interview on Wednesday, Tesla uber bull Ron Baron said that anyone looking to buy the company’s stock should do so as soon as they can.

Baron, founder and CEO of Baron Capital and one of Tesla’s most persistent institutional bulls, used a CNBC Squawk Box appearance on Wednesday to deliver a familiar message with fresh urgency: In his opinion, Tesla stock is a buy:

“The time to buy the stock is now. FSD is catching on, and it’s going to be bigger and bigger. 55% of new buyers are buying it (Teslas) with FSD. It’s going to be everywhere. It’s safer.”

The Baron Capital frontman’s case is built around Full Self-Driving. Tesla reported 1.48 million active FSD subscriptions in the second quarter, up 56 percent year over year, and company officials have said roughly 55 percent of new North American deliveries left with a subscription enabled.

Baron framed that attach rate as proof the product is moving from enthusiast extra to default expectation, and as a reason software, not just vehicle volume, should drive the next phase of value.

His conviction on Tesla shares is not theoretical, as Baron Capital made its first Tesla investment in 2014, after years of meetings that began around the 2010 IPO roadshow. The firm later built a large SpaceX position starting in 2017.

Advertisement
-

Baron said those Musk-led bets have generated about $30 billion of the $71 billion in profits Baron Capital has produced for clients. He put the firm’s current exposure at roughly $25 billion in SpaceX and $5 billion in Tesla. Personally, he described SpaceX as his largest holding, at about $5 billion, with about $1.5 billion in Tesla and additional Tesla exposure through the firm’s funds.

That concentration is also a statement of loyalty. Asked about talk of a SpaceX-Tesla combination, Baron said he had already walked Elon Musk through arguments for and against a deal, then declined to repeat them on air. His public position was simpler: “Whatever you decide is better is what I’m going to support,” he said to Musk.

Baron also said that he picked up the farewell edition of the Model S after Tesla decided to sunset the vehicle earlier this year, calling it his favorite car he’s ever driven.

Advertisement
-
Continue Reading

Elon Musk

SpaceX’s next Starship launch is about to attempt its biggest leap yet

SpaceX targets September 22 for Starship Flight 14, its first attempt to reach real orbit.

Published

on

By

SpaceX has set September 22 as the target date for Starship’s 14th test flight, and this one carries a different goal than any of the 13 that came before it. Every previous Starship mission has intentionally flown a suborbital arc, reentering the atmosphere within the same hour it launched. Flight 14 is designed to send the craft into a genuine orbit around Earth for the first time.

The launch window opens at 7:15 a.m. Central time at Starbase in South Texas and runs for 75 minutes, pending regulatory approval, according to SpaceX’s mission description published Tuesday. If the flight goes as planned, Starship will circle the planet roughly six times at an altitude near 275 kilometers over about ten hours before a deorbit burn sends it toward a splashdown in the Pacific Ocean west of Chile, a departure from the Indian Ocean recoveries used on the last several flights.

The mission also marks the first attempt to put a working batch of Starlink V3 satellites into actual service. Flight 13 carried 20 of the new satellites in July, but because that mission never left a suborbital trajectory, the payload reentered along with the ship instead of separating into orbit.

SpaceX tells the FCC that Starship Flight 14 is going to orbit

Each V3 satellite is rated for roughly one terabit per second of downlink capacity, so a successful deployment on Flight 14 would be SpaceX’s largest single jump in network bandwidth since Starlink began flying on Falcon 9.

Flight 13 still did the heavier lifting on the technical side. That July mission flew a deliberately more stressful reentry profile to test Starship’s heat shield, and the ship survived its softest splashdown yet, intact enough for drone inspections shortly after landing. Elon Musk said the flight delivered “all the heat shield data we needed and then some,” a result Teslarati covered in detail when he later said SpaceX had solved the vehicle’s biggest reusability challenge. Flight 14 is where SpaceX starts spending that confidence on an actual orbital insertion rather than another controlled fall back to Earth.

Advertisement
-

One thing Flight 14 will not attempt is a tower catch of the ship. Musk floated the idea right after Flight 13, but walked the timeline back in August, saying a catch attempt was more likely “in a few months.” The Super Heavy booster will still aim for its own recovery, targeting an offshore landing point in the Gulf of America, the same approach used on recent flights.

September 22 is SpaceX’s own target, not a locked date. Starship’s schedule has slipped before over hardware readiness and FAA sign off, and the company has said as much in its own mission notes. But the plan itself represents the clearest marker yet that Starship is moving from a suborbital test program into something meant to carry paying payloads and, eventually, people.

Continue Reading

Elon Musk

Elon Musk gives his most telling Tesla-SpaceX merger conversation yet

Elon Musk hinted a Tesla-SpaceX merger could be coming, and Wall Street is taking notice.

Published

on

By

Elon Musk gave his clearest signal yet that Tesla and SpaceX could eventually combine, telling the All-In Summit in Los Angeles that the two companies’ deepening collaboration makes the question worth asking. Sawyer Merritt first surfaced the highlight on X Tuesday.

Asked directly why Tesla and SpaceX remain separate given how closely they already work together, Musk told hosts at the summit: “Great question there. With all this collaboration, on so many levels, who can imagine what action one might take when there’s so much close collaboration in so many areas.” SpaceX President Gwynne Shotwell, who joined Musk on stage, added that SpaceX personnel have already moved into xAI to fill leadership and engineering gaps, saying the businesses are integrating “faster than I thought,” though “not fully integrated yet,”

The comments landed on top of merger speculation that has been building on Wall Street for months. JPMorgan has called a tie-up “strategically coherent on paper,” pointing to overlapping ambitions in AI, robotics, energy, transportation and space. Jefferies went further, estimating Musk could retain roughly 55.3 percent voting control in a deal structured without a premium, a scenario that would still leave room for Tesla shareholders to come out ahead. On Kalshi, traders now put the odds of a merger before 2028 at 66 percent.

Tesla’s stake in SpaceX, still under one percent, traces back to its earlier investment in xAI, which converted to SpaceX equity after SpaceX absorbed the AI company. The two are also jointly building Terafab, a chip facility in Austin meant to serve both Tesla’s AI computing needs and SpaceX’s satellite ambitions. Wedbush analyst Dan Ives has stood by a 2027 merger timeline for months, and Cathie Wood’s ARK Invest recently floated a similar case, an idea Musk pushed back on directly at the time.

Another Tesla SpaceX merger prediction by ARK Invest has Elon Musk talking

Advertisement
-

The timing adds another layer. Tesla has scheduled an October 1 unveiling for its next generation Roadster at a venue near SpaceX’s McGregor, Texas test site, using the phrase “Go for launch” in its promotional material. Both stocks dipped roughly 2 percent Monday before recovering slightly in premarket trading Tuesday, with SpaceX shares up about 0.4 percent and Tesla essentially flat.

Musk stopped short of confirming anything is in motion. But unlike his past denials of a corporate restructuring, this response didn’t rule one out, and it came with Shotwell sitting next to him describing an integration that’s already underway.

Continue Reading